STOCK TITAN

Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, June 2, 2021. STERIS plc (NYSE: STE) is acquiring Cantel Medical in a deal expected to be completed soon pending final closing conditions.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date

Index Name      

Action

Company Name

Ticker

GICS Sector

June 2, 2021

S&P MidCap 400

Addition

Crocs

CROX

Consumer Discretionary


S&P MidCap 400

Deletion

Cantel Medical

CMD

Health Care


S&P SmallCap 600

Addition

Organogenesis Holdings

ORGO

Health Care


S&P SmallCap 600

Deletion

Crocs

CROX

Consumer Discretionary

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indices
index_services@spglobal.com

Media Inquiries
spdji.comms@spglobal.com

Cision View original content:http://www.prnewswire.com/news-releases/crocs-set-to-join-sp-midcap-400-and-organogenesis-to-join-sp-smallcap-600-301300374.html

SOURCE S&P Dow Jones Indices

Crocs, Inc.

NASDAQ:CROX

CROX Rankings

CROX Latest News

CROX Stock Data

8.56B
58.44M
2.9%
95.64%
8.4%
Footwear Manufacturing
Manufacturing
Link
United States of America
BROOMFIELD

About CROX

crocs, inc. (nasdaq: crox) is a world leader in innovative casual footwear for men, women and children with more than $1 billion in annual revenue. the company offers several distinct shoe collections with more than 300 four-season footwear styles. all crocs™ shoes feature croslite™ material, a proprietary, revolutionary technology that gives each pair of shoes the soft, comfortable, lightweight, non-marking and odor-resistant qualities that crocs wearers know and love. crocs fans “get crocs inside” every pair of shoes, from the iconic clog to new sneakers, sandals, boots and heels. since its inception in 2002, crocs has sold more than 200 million pairs of shoes in more than 90 countries around the world.